Insomnia Treatment Market to Grow with a CAGR of 5.48% through 2028
Rising advancements in pharmacological and
non-pharmacological treatments are expected to drive the Global Insomnia
Treatment Market growth in the forecast period, 2024-2028.
According to TechSci Research report, “Insomnia
Treatment Market – Global Industry Size, Share, Trends, Competition
Forecast & Opportunities, 2028”, the Global Insomnia Treatment Market
stood at USD 3.12 billion in 2022 and is anticipated to grow with a CAGR of 5.48%
in the forecast period, 2024-2028. The global insomnia treatment industry is
witnessing substantial growth, driven by a multitude of factors that are
reshaping the landscape of sleep medicine. Insomnia, characterized by
persistent difficulty falling asleep or staying asleep, affects millions of
individuals worldwide, impacting their quality of life and overall health. One
of the primary drivers behind the growth of the global insomnia treatment
market is the escalating prevalence of this sleep disorder. Stress, anxiety,
lifestyle changes, and the 24/7 digital age have all contributed to the
increasing incidence of insomnia. According to the World Sleep Society,
approximately 30% of adults experience short-term insomnia, while 10% suffer
from chronic insomnia.
As more individuals seek treatment for their sleep
disturbances, the demand for insomnia treatment options continues to surge. Increased
awareness about the importance of sleep and its impact on overall health has
prompted more individuals to seek medical attention for their sleep-related
issues. Moreover, healthcare providers are becoming more adept at recognizing
and diagnosing insomnia, leading to more accurate reporting and treatment. This
rising awareness is catalyzing the growth of the insomnia treatment market as
people acknowledge the need for professional help in managing their sleep
disorders.
Pharmacological interventions have long been a
cornerstone of insomnia treatment, and recent advancements in this field have
expanded treatment options. Novel medications with improved safety profiles and
efficacy have entered the market, offering patients more choices for managing
their insomnia. Non-benzodiazepine sleep aids, melatonin agonists, and orexin
receptor antagonists are some examples of these innovative drugs that are
driving market growth. Cognitive-behavioral therapy for insomnia (CBT-I) has
emerged as a highly effective non-pharmacological treatment for insomnia.
Unlike medication, CBT-I addresses the underlying behavioral and psychological
factors contributing to insomnia. It has gained significant traction globally
due to its long-term effectiveness and minimal side effects. As healthcare
providers increasingly recognize the value of CBT-I, it is becoming more widely
available, contributing to the expansion of the global insomnia treatment
market.
Browse over XX market data Figures spread
through XX Pages and an in-depth TOC on "Global Insomnia Treatment Market.”
The integration of technology into sleep medicine is
transforming how individuals monitor and manage their sleep disorders.
Sleep-tracking apps, wearable devices, and smart mattresses provide users with
real-time insights into their sleep patterns, helping them identify issues and
make necessary adjustments. This technological innovation empowers individuals
to take a more proactive role in their insomnia treatment, thus driving market
growth.
The Global Insomnia Treatment Market is segmented into
Type, drugs, distribution channel, regional distribution, and company.
Based on the Type, Chronic Insomnia emerged as the
dominant segment in the global market for Global Insomnia Treatment Market in
2022. The high prevalence naturally results in a substantial demand for
effective treatment options. Chronic insomnia often has complex underlying
causes, including psychological factors, lifestyle, medical conditions, and
behavioral patterns. Its multifactorial nature necessitates a comprehensive
approach to treatment, which may involve a combination of pharmacological and
behavioral therapies. Chronic insomnia often has complex underlying causes,
including psychological factors, lifestyle, medical conditions, and behavioral
patterns. Its multifactorial nature necessitates a comprehensive approach to
treatment, which may involve a combination of pharmacological and behavioral
therapies. The complexity of chronic insomnia drives individuals to seek
professional help, further boosting the demand for insomnia treatment.
Chronic insomnia takes a significant toll on an
individual's overall well-being. Prolonged sleep disturbances can lead to
fatigue, impaired cognitive function, mood disorders, reduced productivity, and
decreased quality of life. As the consequences of untreated chronic insomnia
become more apparent, individuals are motivated to seek treatment, increasing
the demand for effective solutions.
Based on the Drugs, the Zolpidem emerged as the
dominant player in the global market for Global Insomnia Treatment Market in
2022. Zolpidem has a well-established track record for effectively treating
insomnia. It is a non-benzodiazepine sedative-hypnotic medication that acts on
the central nervous system to induce sleep. Many individuals with insomnia have
found relief through zolpidem, which has contributed to its widespread
acceptance. Zolpidem is known for its relatively short half-life and reduced risk of
next-day drowsiness compared to older benzodiazepine sleep aids. This
characteristic makes it a preferred choice for individuals who need a
medication that allows them to wake up feeling refreshed and alert. Zolpidem is
available in various formulations, including immediate-release (IR) and
extended-release (ER) versions. The different formulations cater to the diverse
needs of patients, allowing healthcare providers to prescribe the most suitable
option based on the individual's specific sleep patterns and requirements.
Based on the distribution channel, the retail
pharmacies emerged as the dominant player in the global market for Global Insomnia
Treatment Market in 2022. Retail pharmacies are easily accessible to the general
population. They are typically located in neighborhoods, shopping centers, and
urban areas, making it convenient for individuals to visit and purchase their
prescribed insomnia medications. This accessibility ensures that patients have
a nearby source for their medication needs. retail pharmacies have the
infrastructure and expertise to process and fill prescriptions promptly. When
healthcare providers prescribe insomnia medications, patients can take their
prescription to a nearby retail pharmacy, ensuring timely access to their
treatment.
North America emerged as the dominant player in the
global Insomnia Treatment Market in
2022, holding the largest market share. North America has a notably high
prevalence of insomnia, with a significant portion of its population
experiencing sleep disturbances. Factors such as stress, lifestyle changes, and
the prevalence of underlying health conditions have contributed to the
widespread occurrence of insomnia in the region, creating a substantial demand
for insomnia treatment. The region has a strong emphasis on medical research
and development, including advancements in the field of sleep medicine. Ongoing
research initiatives, clinical trials, and collaborations between academia and
industry have led to the development of innovative insomnia treatments,
attracting global attention and investment.
Major companies operating in Global Insomnia
Treatment Market are:
- Merck & Co
- Pfizer Inc.
- Abbott
- Genentech
- LGM Pharma
- Sigma Aldrich
- Sanofi S.A
- Takeda
Pharmaceuticals
- Eisai Ltd.
- Idorsia
Pharmaceuticals Apotex Corp
Download Free Sample Report
Customers can also request for 10% free customization
on this report.
“The global
insomnia treatment market is poised for substantial growth in the coming years,
driven by several key factors. Firstly, the increasing prevalence of insomnia,
fueled by modern lifestyles, stress, and the rising incidence of comorbid
conditions, is creating a significant patient pool seeking treatment. This
growing awareness of the importance of sleep health is propelling individuals
to seek medical intervention for their sleep disturbances, boosting market
demand. Secondly, advancements in pharmacological and non-pharmacological
treatments are expanding the range of options available to patients. The
development of safer and more effective medications, as well as innovative
behavioral therapies, is enhancing treatment outcomes and patient satisfaction,
further stimulating market growth. Moreover, a growing emphasis on mental
health and well-being is leading to integrated approaches to insomnia
treatment. As the link between insomnia and mental health becomes better
understood, healthcare providers are addressing both issues concurrently,
broadening the scope of insomnia care.” said Mr. Karan Chechi, Research
Director with TechSci Research, a research-based management consulting firm.
“Insomnia Treatment Market - Global Industry Size, Share, Trends,
Opportunity, and Forecast, 2018-2028 Segmented By Type (Acute Insomnia Chronic
Insomnia, Onset Insomnia, Maintenance Insomnia, Behavioral Insomnia of
Childhood), By Drugs (Eszopiclone, Ramelteon, Zaleplon, Zolpidem, Estazolam,
Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies,
Online Pharmacies) By Region and Competition”, has evaluated the future growth
potential of Global Insomnia Treatment Market and provides statistics &
information on market size, structure and future market growth. The report
intends to provide cutting-edge market intelligence and help decision makers
take sound investment decisions. Besides, the report also identifies and
analyzes the emerging trends along with essential drivers, challenges, and
opportunities in Global Insomnia Treatment Market.
Contact
Mr. Ken
Mathews
708 Third
Avenue,
Manhattan, NY,
New York –
10017
Tel:
+1-646-360-1656
Email: [email protected]
Website: www.techsciresearch.com